搜索临床试验以:TTI-622 PD-1 Inhibitor
总计5236个结果
-
PfizerIncyte Corporation; MorphoSys AG招聘中
-
Pfizer主动,不招人肾细胞癌 | 胃癌 | 胰腺癌 | 食道癌 | 卵巢癌 | 头颈部鳞状细胞癌 | 胆管癌 | 子宫内膜癌 | 尿路上皮癌 | 肺鳞状细胞癌 | 黑色素瘤癌症美国, 台湾, 大韩民国, 澳大利亚, 斯洛伐克
-
The First Affiliated Hospital of Guangdong Pharmaceutical...Guangzhou Anjie Biomedical Technology Co., Ltd.未知
-
Second Affiliated Hospital of Soochow UniversitySciClone Pharmaceuticals招聘中
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials Limited招聘中
-
Jason J. Luke, MD招聘中黑色素瘤 | 宫颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 非小细胞肺癌 | 晚期实体瘤 | 胆管癌 | 膀胱癌 | 肾癌 | 肛门癌 | 默克尔细胞癌 | HNSCC美国
-
Mahmoud Ramadan mohamed Elkazzaz尚未招聘
-
Buzzard PharmaceuticalsBaylor Research Institute招聘中
-
Beijing YouAn HospitalBeijing Gene Key Life Technology Co., Ltd.招聘中
-
Second Affiliated Hospital of Soochow University尚未招聘
-
Peking University First HospitalYiZhou International Cancer Hospital未知免疫疗法 | 质子治疗
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
The First Affiliated Hospital with Nanjing Medical...招聘中
-
OncoC4, Inc.Avance Clinical; OncoC4 AU Pty Ltd招聘中黑色素瘤 | 肾细胞癌 | 宫颈癌 | 肝细胞癌 | 胃癌 | 大肠癌 | 食道癌 | 输卵管癌 | 非小细胞肺癌 | 胆管癌 | 膀胱癌 | 子宫内膜癌 | 头颈部鳞状细胞癌 | 肛门癌 | 原发性腹膜癌 | 卵巢高级别浆液性腺癌 | 胃食管结合部癌澳大利亚
-
Shanghai Cell Therapy Research Institute未知
-
Tianjin Medical University Cancer Institute and...Jiangsu HengRui Medicine Co., Ltd.完全的
-
Chinese PLA General HospitalLinkDoc Technology (Beijing) Co. Ltd.未知
-
Fudan UniversityShanxi Province Cancer Hospital; Inner Mongolia Cancer Hospital Affiliated To Inner Mongolia...招聘中
-
M.D. Anderson Cancer Center撤销
-
Northwestern UniversityNational Cancer Institute (NCI)招聘中
-
Sixth Affiliated Hospital, Sun Yat-sen University招聘中
-
Shanghai Zhongshan HospitalJining Medical University; Cancer Hospital of Guangxi Medical University主动,不招人
-
Shanghai Cell Therapy Research Institute未知
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)完全的